{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:52:25Z","timestamp":1782143545292,"version":"3.54.5"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T00:00:00Z","timestamp":1556236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00011-019-01240-0","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T03:17:31Z","timestamp":1556335051000},"page":"459-469","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The role of the complement system in HIV infection and preeclampsia"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9636-4145","authenticated-orcid":false,"given":"Yazira","family":"Pillay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagidesa","family":"Moodley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thajasvarie","family":"Naicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,26]]},"reference":[{"key":"1240_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/imr.12066","volume":"254","author":"AA Okoye","year":"2013","unstructured":"Okoye AA, Picker LJ. CD4(+) T cell depletion in HIV infection: mechanisms of immunological failure. Immunol Rev. 2013;254:54\u201364.","journal-title":"Immunol Rev"},{"key":"1240_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0140-6736(14)60164-1","volume":"384","author":"G Maartens","year":"2014","unstructured":"Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet. 2014;384:258\u201371.","journal-title":"Lancet"},{"key":"1240_CR3","volume-title":"UNAIDS data","author":"UNAIDS","year":"2018","unstructured":"UNAIDS. UNAIDS data. Geneva: UNAIDS; 2018."},{"key":"1240_CR4","volume-title":"Ending AIDS: progress towards 90-90-90 targets","author":"UNAIDS","year":"2017","unstructured":"UNAIDS. Ending AIDS: progress towards 90-90-90 targets. Geneva: UNAIDS; 2017."},{"key":"1240_CR5","volume-title":"Statistical release P0302 mid-year population estimates 2018","author":"Statistics South Africa","year":"2018","unstructured":"Statistics South Africa. Statistical release P0302 mid-year population estimates 2018. Pretoria: Stats SA; 2018."},{"key":"1240_CR6","volume-title":"Saving mothers 2014\u20132016: seventh triennial report on confidential enquiries into maternal deaths in South Africa: short report","author":"National Committee on Confidential Enquiries into Maternal Deaths","year":"2018","unstructured":"National Committee on Confidential Enquiries into Maternal Deaths. Saving mothers 2014\u20132016: seventh triennial report on confidential enquiries into maternal deaths in South Africa: short report. Pretoria: National Department of Health; 2018."},{"key":"1240_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/10641955.2016.1193190","volume":"35","author":"J Moodley","year":"2016","unstructured":"Moodley J, Onyangunga OA, Maharaj NR. Hypertensive disorders in primigravid black South African women: a one-year descriptive analysis. Hypertens Pregnancy. 2016;35:529\u201335.","journal-title":"Hypertens Pregnancy"},{"key":"1240_CR8","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1161\/HYPERTENSIONAHA.112.202747","volume":"60","author":"JS Gilbert","year":"2012","unstructured":"Gilbert JS, Banek CT, Katz V, Babcock S, Regal JF. Complement activation in pregnancy: too much of a good thing? Hypertension. 2012;60:1114\u20136.","journal-title":"Hypertension"},{"key":"1240_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","volume":"72","author":"MA Brown","year":"2018","unstructured":"Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72:24\u201343.","journal-title":"Hypertension"},{"key":"1240_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ogc.2010.02.013","volume":"37","author":"M Silasi","year":"2010","unstructured":"Silasi M, Cohen B, Karumanchi SA, Rana S. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin N Am. 2010;37:239\u201353.","journal-title":"Obstet Gynecol Clin N Am"},{"key":"1240_CR11","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1016\/j.ajog.2015.08.042","volume":"213","author":"SJ Fisher","year":"2015","unstructured":"Fisher SJ. Why is placentation abnormal in preeclampsia? Am J Obstet Gynecol. 2015;213:S115\u201322.","journal-title":"Am J Obstet Gynecol"},{"key":"1240_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preghy.2017.01.004","volume":"8","author":"RD Williamson","year":"2017","unstructured":"Williamson RD, McCarthy C, McCarthy FP, Kenny LC. Oxidative stress in pre-eclampsia; have we been looking in the wrong place? Pregnancy Hypertens. 2017;8:1\u20135.","journal-title":"Pregnancy Hypertens"},{"key":"1240_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11906-017-0784-4","volume":"19","author":"JF Regal","year":"2017","unstructured":"Regal JF, Burwick RM, Fleming SD. The complement system and preeclampsia. Curr Hypertens Rep. 2017;19:87.","journal-title":"Curr Hypertens Rep"},{"key":"1240_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3389\/fimmu.2014.00125","volume":"5","author":"P Hsu","year":"2014","unstructured":"Hsu P, Nanan RKH. Innate and adaptive immune interactions at the fetal-maternal interface in healthy human pregnancy and pre-eclampsia. Front Immunol. 2014;5:125.","journal-title":"Front Immunol"},{"key":"1240_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fimmu.2014.00244","volume":"5","author":"A Perez-Sepulveda","year":"2014","unstructured":"Perez-Sepulveda A, Torres MJ, Khoury M, Illanes SE. Innate immune system and preeclampsia. Front Immunol. 2014;5:244.","journal-title":"Front Immunol"},{"key":"1240_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejogrb.2016.12.008","volume":"210","author":"HM Sebitloane","year":"2017","unstructured":"Sebitloane HM, Moodley D. The impact of highly active antiretroviral therapy on obstetric conditions: a review. Eur J Obstet Gynecol Reprod Biol. 2017;210:126\u201331.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1240_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.hivar.2015.07.004","volume":"15","author":"MAY Alqudah","year":"2016","unstructured":"Alqudah MAY, Yaseen MMM, Yaseen MMS. HIV-1 strategies to overcome the immune system by evading and invading innate immune system. HIV AIDS Rev. 2016;15:1\u201312.","journal-title":"HIV AIDS Rev"},{"key":"1240_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/aji.12000","volume":"69","author":"KJ Denny","year":"2013","unstructured":"Denny KJ, Woodruff TM, Taylor SM, Callaway LK. Complement in pregnancy: a delicate balance. Am J Reprod Immunol. 2013;69:3\u201311.","journal-title":"Am J Reprod Immunol"},{"key":"1240_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/cmi.2010.8","volume":"7","author":"Q Yu","year":"2010","unstructured":"Yu Q, Yu R, Qin X. The good and evil of complement activation in HIV-1 infection. Cell Mol Immunol. 2010;7:334\u201340.","journal-title":"Cell Mol Immunol."},{"key":"1240_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00441-010-1034-0","volume":"343","author":"JV Sarma","year":"2011","unstructured":"Sarma JV, Ward PA. The complement system. Cell Tissue Res. 2011;343:227\u201335.","journal-title":"Cell Tissue Res"},{"key":"1240_CR21","first-page":"262","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT. Complement system part I\u2014molecular mechanisms of activation and regulation. Front Immunol. 2015;6:262.","journal-title":"Front Immunol"},{"key":"1240_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","volume":"33","author":"M Noris","year":"2013","unstructured":"Noris M, Remuzzi G. Overview of complement activation and regulation. Semin Nephrol. 2013;33:479\u201392.","journal-title":"Semin Nephrol"},{"key":"1240_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3389\/fimmu.2014.00312","volume":"5","author":"AI Lokki","year":"2014","unstructured":"Lokki AI, Heikkinen-Eloranta J, Jarva H, Saisto T, Lokki M-L, Laivuori H, et al. Complement activation and regulation in preeclamptic placenta. Front Immunol. 2014;5:312.","journal-title":"Front Immunol"},{"key":"1240_CR24","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3389\/fmicb.2015.01460","volume":"6","author":"CR McDonald","year":"2015","unstructured":"McDonald CR, Tran V, Kain KC. Complement activation in placental malaria. Front Microbiol. 2015;6:1460.","journal-title":"Front Microbiol"},{"key":"1240_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.dci.2014.01.010","volume":"46","author":"S Zhang","year":"2014","unstructured":"Zhang S, Cui P. Complement system in zebrafish. Dev Comp Immunol. 2014;46:3\u201310.","journal-title":"Dev Comp Immunol"},{"key":"1240_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.molimm.2015.02.030","volume":"67","author":"JF Regal","year":"2015","unstructured":"Regal JF, Gilbert JS, Burwick RM. The complement system and adverse pregnancy outcomes. Mol Immunol. 2015;67:56\u201370.","journal-title":"Mol Immunol"},{"key":"1240_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00281-017-0644-y","volume":"40","author":"J Killick","year":"2018","unstructured":"Killick J, Morisse G, Sieger D, Astier AL. Complement as a regulator of adaptive immunity. Semin Immunopathol. 2018;40:37\u201348.","journal-title":"Semin Immunopathol"},{"key":"1240_CR28","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.molimm.2010.01.021","volume":"47","author":"Z Derzsy","year":"2010","unstructured":"Derzsy Z, Prohaszka Z, Rigo J Jr, Fust G, Molvarec A. Activation of the complement system in normal pregnancy and preeclampsia. Mol Immunol. 2010;47:1500\u20136.","journal-title":"Mol Immunol"},{"key":"1240_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/imr.12475","volume":"274","author":"CQ Schmidt","year":"2016","unstructured":"Schmidt CQ, Lambris JD, Ricklin D. Protection of host cells by complement regulators. Immunol Rev. 2016;274:152\u201371.","journal-title":"Immunol Rev"},{"key":"1240_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11906-018-0836-4","volume":"20","author":"L Alrahmani","year":"2018","unstructured":"Alrahmani L, Willrich MAV. The complement alternative pathway and preeclampsia. Curr Hypertens Rep. 2018;20:40.","journal-title":"Curr Hypertens Rep"},{"key":"1240_CR31","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1515\/jpm-2017-0073","volume":"45","author":"K Lannaman","year":"2017","unstructured":"Lannaman K, Romero R, Chaiworapongsa T, Kim YM, Korzeniewski SJ, Maymon E, et al. Fetal death: an extreme manifestation of maternal anti-fetal rejection. J Perinat Med. 2017;45:851\u201368.","journal-title":"J Perinat Med"},{"key":"1240_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/14767050500072722","volume":"17","author":"K Richani","year":"2005","unstructured":"Richani K, Soto E, Romero R, Espinoza J, Chaiworapongsa T, Nien JK, et al. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med. 2005;17:239\u201345.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"1240_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1600-0897.1999.tb00448.x","volume":"41","author":"A Albieri","year":"1999","unstructured":"Albieri A, Kipnis T, Bevilacqua E. A possible role for activated complement component 3 in phagocytic activity exhibited by the mouse trophoblast. Am J Reprod Immunol. 1999;41:343\u201352.","journal-title":"Am J Reprod Immunol"},{"key":"1240_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jri.2009.06.124","volume":"82","author":"R Bulla","year":"2009","unstructured":"Bulla R, Bossi F, Agostinis C, Radillo O, Colombo F, De Seta F, et al. Complement production by trophoblast cells at the feto-maternal interface. J Reprod Immunol. 2009;82:119\u201325.","journal-title":"J Reprod Immunol"},{"key":"1240_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fimmu.2012.00055","volume":"3","author":"R Bulla","year":"2012","unstructured":"Bulla R, Bossi F, Tedesco F. The complement system at the embryo implantation site: friend or foe? Front Immunol. 2012;3:55.","journal-title":"Front Immunol"},{"key":"1240_CR36","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.imbio.2016.06.002","volume":"221","author":"SP Madhukaran","year":"2016","unstructured":"Madhukaran SP, Alhamlan FS, Kale K, Vatish M, Madan T, Kishore U. Role of collectins and complement protein C1q in pregnancy and parturition. Immunobiology. 2016;221:1273\u201388.","journal-title":"Immunobiology."},{"key":"1240_CR37","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1161\/HYPERTENSIONAHA.111.175919","volume":"58","author":"J Singh","year":"2011","unstructured":"Singh J, Ahmed A, Girardi G. Role of complement component C1q in the onset of preeclampsia in mice. Hypertension. 2011;58:716\u201324.","journal-title":"Hypertension."},{"key":"1240_CR38","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/mrd.21013","volume":"76","author":"FW-N Chow","year":"2009","unstructured":"Chow FW-N, Lee Y-L, Wong P-C, Chung M-K, Lee K-F, Shu-Biu YW. Complement 3 deficiency impairs early pregnancy in mice. Mol Reprod Dev. 2009;76:647\u201355.","journal-title":"Mol Reprod Dev"},{"key":"1240_CR39","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3389\/fimmu.2017.00589","volume":"8","author":"AI Lokki","year":"2017","unstructured":"Lokki AI, Kaartokallio T, Holmberg V, Onkamo P, Koskinen LLE, Saavalainen P, et al. Analysis of complement C3 gene reveals susceptibility to severe preeclampsia. Front Immunol. 2017;8:589.","journal-title":"Front Immunol"},{"key":"1240_CR40","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.placenta.2010.03.010","volume":"31","author":"AM Lynch","year":"2010","unstructured":"Lynch AM, Salmon JE. Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications. Placenta. 2010;31:561\u20137.","journal-title":"Placenta"},{"key":"1240_CR41","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/hr.2016.152","volume":"40","author":"T Tomimatsu","year":"2017","unstructured":"Tomimatsu T, Mimura K, Endo M, Kumasawa K, Kimura T. Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction. Hypertens Res. 2017;40:305\u201310.","journal-title":"Hypertens Res"},{"key":"1240_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-pathol-121808-102149","volume":"5","author":"BC Young","year":"2010","unstructured":"Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol. 2010;5:173\u201392.","journal-title":"Annu Rev Pathol"},{"key":"1240_CR43","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.4049\/jimmunol.1402220","volume":"195","author":"SE Gelber","year":"2015","unstructured":"Gelber SE, Brent E, Redecha P, Perino G, Tomlinson S, Davisson RL, et al. Prevention of defective placentation and pregnancy loss by blocking innate immune pathways in a syngeneic model of placental insufficiency. J Immunol. 2015;195:1129\u201338.","journal-title":"J Immunol"},{"key":"1240_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molimm.2013.04.009","volume":"56","author":"KE Lillegard","year":"2013","unstructured":"Lillegard KE, Johnson AC, Lojovich SJ, Bauer AJ, Marsh HC, Gilbert JS, et al. Complement activation is critical for placental ischemia-induced hypertension in the rat. Mol Immunol. 2013;56:91\u20137.","journal-title":"Mol Immunol"},{"key":"1240_CR45","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/jcmm.13466","volume":"22","author":"Y Ma","year":"2018","unstructured":"Ma Y, Kong LR, Ge Q, Lu YY, Hong MN, Zhang Y, et al. Complement 5a-mediated trophoblasts dysfunction is involved in the development of pre-eclampsia. J Cell Mol Med. 2018;22:1034\u201346.","journal-title":"J Cell Mol Med"},{"key":"1240_CR46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.placenta.2012.11.014","volume":"34","author":"RM Burwick","year":"2013","unstructured":"Burwick RM, Feinberg BB. Eculizumab for the treatment of preeclampsia\/HELLP syndrome. Placenta. 2013;34:201\u20133.","journal-title":"Placenta"},{"key":"1240_CR47","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00011-016-0968-4","volume":"65","author":"W Wu","year":"2016","unstructured":"Wu W, Yang H, Feng Y, Zhang P, Li S, Wang X, et al. Polymorphisms in complement genes and risk of preeclampsia in Taiyuan, China. Inflamm Res. 2016;65:837\u201345.","journal-title":"Inflamm Res"},{"key":"1240_CR48","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.3389\/fimmu.2018.01813","volume":"9","author":"FC Mohlin","year":"2018","unstructured":"Mohlin FC, Gros P, Mercier E, Gris JR, Blom AM. Analysis of C3 gene variants in patients with idiopathic recurrent spontaneous pregnancy loss. Front Immunol. 2018;9:1813.","journal-title":"Front Immunol"},{"key":"1240_CR49","doi-asserted-by":"publisher","first-page":"e1001013","DOI":"10.1371\/journal.pmed.1001013","volume":"8","author":"JE Salmon","year":"2011","unstructured":"Salmon JE, Heuser C, Triebwasser M, Liszewski MK, Kavanagh D, Roumenina L, et al. Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Med. 2011;8:e1001013.","journal-title":"PLoS Med"},{"key":"1240_CR50","doi-asserted-by":"publisher","first-page":"e0117840","DOI":"10.1371\/journal.pone.0117840","volume":"10","author":"AI Lokki","year":"2015","unstructured":"Lokki AI, Aalto-Viljakainen T, Meri S, Laivuori H. Genetic analysis of membrane cofactor protein (CD46) of the complement system in women with and without preeclamptic pregnancies. PLoS One. 2015;10:e0117840.","journal-title":"PLoS One"},{"key":"1240_CR51","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nrneph.2014.102","volume":"10","author":"T Chaiworapongsa","year":"2014","unstructured":"Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10:466.","journal-title":"Nat Rev Nephrol"},{"key":"1240_CR52","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/10641955.2016.1190845","volume":"35","author":"Y He","year":"2016","unstructured":"He Y, Xu B, Song D, Yu F, Chen Q, Zhao M. Correlations between complement system\u2019s activation factors and anti-angiogenesis factors in plasma of patients with early\/late-onset severe preeclampsia. Hypertens Pregnancy. 2016;35:499\u2013509.","journal-title":"Hypertens Pregnancy"},{"key":"1240_CR53","doi-asserted-by":"publisher","first-page":"e13033","DOI":"10.1111\/aji.13033","volume":"80","author":"M Banadakoppa","year":"2018","unstructured":"Banadakoppa M, Balakrishnan M, Yallampalli C. Upregulation and release of soluble fms-like tyrosine kinase receptor 1 mediated by complement activation in human syncytiotrophoblast cells. Am J Reprod Immunol. 2018;80:e13033.","journal-title":"Am J Reprod Immunol"},{"key":"1240_CR54","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/aji.12349","volume":"73","author":"SH Guseh","year":"2015","unstructured":"Guseh SH, Feinberg BB, Dawood HY, Yamamoto HS, Fichorova RN, Burwick RM. Urinary excretion of C5b-9 is associated with the anti-angiogenic state in severe preeclampsia. Am J Reprod Immunol. 2015;73:437\u201344.","journal-title":"Am J Reprod Immunol"},{"key":"1240_CR55","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1096\/fj.201701008R","volume":"32","author":"JL Sones","year":"2018","unstructured":"Sones JL, Merriam AA, Seffens A, Brown-Grant DA, Butler SD, Zhao AM, et al. Angiogenic factor imbalance precedes complement deposition in placentae of the BPH\/5 model of preeclampsia. FASEB J. 2018;32:2574\u201386.","journal-title":"FASEB J"},{"key":"1240_CR56","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/aji.12439","volume":"75","author":"AM Lynch","year":"2016","unstructured":"Lynch AM, Wagner BD, Giclas PC, West NA, Gibbs RS, Holers VM. The relationship of longitudinal levels of complement bb during pregnancy with preeclampsia. Am J Reprod Immunol. 2016;75:104\u201311.","journal-title":"Am J Reprod Immunol"},{"key":"1240_CR57","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jri.2014.12.002","volume":"109","author":"I Velickovic","year":"2015","unstructured":"Velickovic I, Dalloul M, Wong KA, Bakare O, Schweis F, Garala M, et al. Complement factor B activation in patients with preeclampsia. J Reprod Immunol. 2015;109:94\u2013100.","journal-title":"J Reprod Immunol"},{"key":"1240_CR58","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/aji.12162","volume":"71","author":"MC Hoffman","year":"2014","unstructured":"Hoffman MC, Rumer KK, Kramer A, Lynch AM, Winn VD. Maternal and fetal alternative complement pathway activation in early severe preeclampsia. Am J Reprod Immunol. 2014;71:55\u201360.","journal-title":"Am J Reprod Immunol"},{"key":"1240_CR59","doi-asserted-by":"publisher","first-page":"263109","DOI":"10.1155\/2015\/263109","volume":"2015","author":"M Banadakoppa","year":"2015","unstructured":"Banadakoppa M, Vidaeff AC, Yallampalli U, Ramin SM, Belfort MA, Yallampalli C. Complement split products in amniotic fluid in pregnancies subsequently developing early-onset preeclampsia. Dis Markers. 2015;2015:263109.","journal-title":"Dis Markers"},{"key":"1240_CR60","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jri.2012.11.006","volume":"97","author":"KJ Denny","year":"2013","unstructured":"Denny KJ, Coulthard LG, Finnell RH, Callaway LK, Taylor SM, Woodruff TM. Elevated complement factor C5a in maternal and umbilical cord plasma in preeclampsia. J Reprod Immunol. 2013;97:211\u20136.","journal-title":"J Reprod Immunol"},{"key":"1240_CR61","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/HYPERTENSIONAHA.113.01420","volume":"62","author":"RM Burwick","year":"2013","unstructured":"Burwick RM, Fichorova RN, Dawood HY, Yamamoto HS, Feinberg BB. Urinary excretion of C5b-9 in severe preeclampsia: tipping the balance of complement activation in pregnancy. Hypertension. 2013;62:1040\u20135.","journal-title":"Hypertension"},{"key":"1240_CR62","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2217\/17460794.3.3.225","volume":"3","author":"S Eisen","year":"2008","unstructured":"Eisen S, Dzwonek A, Klein NJ. Mannose-binding lectin in HIV infection. Future Virol. 2008;3:225\u201333.","journal-title":"Future Virol"},{"key":"1240_CR63","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s13365-014-0243-9","volume":"20","author":"F Liu","year":"2014","unstructured":"Liu F, Dai S, Gordon J, Qin X. Complement and HIV-I infection\/HIV-associated neurocognitive disorders. J Neurovirol. 2014;20:184\u201398.","journal-title":"J Neurovirol"},{"key":"1240_CR64","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1744-313X.2010.00946.x","volume":"37","author":"A Sheng","year":"2010","unstructured":"Sheng A, Lan J, Wu H, Lu J, Wang Y, Chu Q, et al. A clinical case\u2013control study on the association between mannose-binding lectin and susceptibility to HIV-1 infection among northern Han Chinese population. Int J Immunogenet. 2010;37:445\u201354.","journal-title":"Int J Immunogenet"},{"key":"1240_CR65","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.molimm.2009.08.020","volume":"47","author":"Y Tan","year":"2009","unstructured":"Tan Y, Liu L, Luo P, Wang A, Jia T, Shen X, et al. Association between mannose-binding lectin and HIV infection and progression in a Chinese population. Mol Immunol. 2009;47:632\u20138.","journal-title":"Mol Immunol"},{"key":"1240_CR66","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.meegid.2013.09.010","volume":"20","author":"H Li","year":"2013","unstructured":"Li H, Fu WP, Hong ZH. Replication study in Chinese Han population and meta-analysis supports association between the MBL2 gene polymorphism and HIV-1 infection. Infect Genet Evol. 2013;20:163\u201370.","journal-title":"Infect Genet Evol"},{"key":"1240_CR67","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1034\/j.1600-065X.2001.1800115.x","volume":"180","author":"H Stoiber","year":"2001","unstructured":"Stoiber H, Kacani L, Speth C, Wurzner R, Dierich MP. The supportive role of complement in HIV pathogenesis. Immunol Rev. 2001;180:168\u201376.","journal-title":"Immunol Rev"},{"key":"1240_CR68","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1365-2796.2007.01819.x","volume":"262","author":"M Huber","year":"2007","unstructured":"Huber M, Trkola A. Humoral immunity to HIV-1: neutralization and beyond. J Intern Med. 2007;262:5\u201325.","journal-title":"J Intern Med"},{"key":"1240_CR69","doi-asserted-by":"publisher","first-page":"359","DOI":"10.4049\/jimmunol.0902278","volume":"184","author":"W Hu","year":"2010","unstructured":"Hu W, Yu Q, Hu N, Byrd D, Amet T, Shikuma C, et al. A high-affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: implications for treatment of HIV-1\/AIDS. J Immunol. 2010;184:359\u201368.","journal-title":"J Immunol"},{"key":"1240_CR70","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3389\/fimmu.2018.00899","volume":"9","author":"R Ellegard","year":"2018","unstructured":"Ellegard R, Khalid M, Svanberg C, Holgersson H, Thoren Y, Wittgren MK, et al. Complement-opsonized HIV-1 alters cross talk between dendritic cells and natural killer (NK) cells to inhibit NK killing and to upregulate PD-1, CXCR70, and CCR70 on T cells. Front Immunol. 2018;9:899.","journal-title":"Front Immunol"},{"key":"1240_CR71","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/eji.201242935","volume":"43","author":"V Tjomsland","year":"2013","unstructured":"Tjomsland V, Ellegard R, Burgener A, Mogk K, Che KF, Westmacott G, et al. Complement opsonization of HIV-1 results in a different intracellular processing pattern and enhanced MHC class I presentation by dendritic cells. Eur J Immunol. 2013;43:1470\u201383.","journal-title":"Eur J Immunol"},{"key":"1240_CR72","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.4049\/jimmunol.1401781","volume":"193","author":"R Ellegard","year":"2014","unstructured":"Ellegard R, Crisci E, Burgener A, Sjowall C, Birse K, Westmacott G, et al. Complement opsonization of HIV-1 results in decreased antiviral and inflammatory responses in immature dendritic cells via CR3. J Immunol. 2014;193:4590\u2013601.","journal-title":"J Immunol."},{"key":"1240_CR73","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.molimm.2018.02.011","volume":"96","author":"N Mishra","year":"2018","unstructured":"Mishra N, Mohata M, Aggarwal H, Chaudhary O, Das BK, Sinha S, et al. Expression of complement receptor 3 (CR3) and regulatory protein CD46 on dendritic cells of antiretroviral naive and treated HIV-1 infected individuals: correlation with immune activation status. Mol Immunol. 2018;96:83\u20137.","journal-title":"Mol Immunol."},{"key":"1240_CR74","doi-asserted-by":"publisher","first-page":"1179545X1775232","DOI":"10.1177\/1179545X17752325","volume":"11","author":"DC Cornelius","year":"2018","unstructured":"Cornelius DC. Preeclampsia: from inflammation to immunoregulation. Clin Med Insights Blood Disord. 2018;11:1179545X17752325.","journal-title":"Clin Med Insights Blood Disord."},{"key":"1240_CR75","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1042\/CS20150702","volume":"130","author":"AC Harmon","year":"2016","unstructured":"Harmon AC, Cornelius DC, Amaral LM, Faulkner JL, Cunningham MW Jr, Wallace K, et al. The role of inflammation in the pathology of preeclampsia. Clin Sci. 2016;130:409\u201319.","journal-title":"Clin Sci"},{"key":"1240_CR76","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/QAI.0000000000001079","volume":"73","author":"AEB Rossheim","year":"2016","unstructured":"Rossheim AEB, Cunningham TD, Hair PS, Shah T, Cunnion KM, Troy SB. Effects of well-controlled HIV infection on complement activation and function. J Acquir Immune Defic Syndr. 2016;73:20\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1240_CR77","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.4049\/jimmunol.1203487","volume":"190","author":"D Ricklin","year":"2013","unstructured":"Ricklin D, Lambris JD. Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol. 2013;190:3831\u20138.","journal-title":"J Immunol"},{"key":"1240_CR78","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.4049\/jimmunol.166.5.3410","volume":"166","author":"L Kacani","year":"2001","unstructured":"Kacani L, Banki Z, Zwirner J, Schennach H, Bajtay Z, Erdei A, et al. C5a and C5a(desArg) enhance the susceptibility of monocyte-derived macrophages to HIV infection. J Immunol. 2001;166:3410\u20135.","journal-title":"J Immunol"},{"issue":"Suppl 2","key":"1240_CR79","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/2047-783X-15-S2-120","volume":"15","author":"K Popko","year":"2010","unstructured":"Popko K, Gorska E, Stelmaszczyk-Emmel A, Plywaczewski R, Stoklosa A, Gorecka D, et al. Proinflammatory cytokines Il-6 and TNF-alpha and the development of inflammation in obese subjects. Eur J Med Res. 2010;15(Suppl 2):120\u20132.","journal-title":"Eur J Med Res"},{"key":"1240_CR80","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/infdis\/jiv074","volume":"212","author":"MAM Huson","year":"2015","unstructured":"Huson MAM, Wouters D, van Mierlo G, Grobusch MP, Zeerleder SS, van der Poll T. HIV coinfection enhances complement activation during sepsis. J Infect Dis. 2015;212:474\u201383.","journal-title":"J Infect Dis"},{"key":"1240_CR81","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejogrb.2016.06.004","volume":"204","author":"R Khan","year":"2016","unstructured":"Khan R, Maduray K, Moodley J, Naicker T. Activation of CD35 and CD55 in HIV associated normal and pre-eclamptic pregnant women. Eur J Obstet Gynecol Reprod Biol. 2016;204:51\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1240_CR82","doi-asserted-by":"publisher","first-page":"e12647","DOI":"10.1111\/aji.12647","volume":"77","author":"W Zhang","year":"2017","unstructured":"Zhang W, Zhou Y, Ding Y. Lnc-DC mediates the over-maturation of decidual dendritic cells and induces the increase in Th1 cells in preeclampsia. Am J Reprod Immunol. 2017;77:e12647.","journal-title":"Am J Reprod Immunol."},{"key":"1240_CR83","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1471-4906(02)02281-0","volume":"23","author":"MB Lutz","year":"2002","unstructured":"Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 2002;23:445\u20139.","journal-title":"Trends Immunol"},{"key":"1240_CR84","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.ajpath.2012.08.032","volume":"181","author":"P Hsu","year":"2012","unstructured":"Hsu P, Santner-Nanan B, Dahlstrom JE, Fadia M, Chandra A, Peek M, et al. Altered decidual DC-SIGN\u2009+\u2009antigen-presenting cells and impaired regulatory T-cell induction in preeclampsia. Am J Pathol. 2012;181:2149\u201360.","journal-title":"Am J Pathol"},{"key":"1240_CR85","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/aid.2015.0179","volume":"32","author":"AK Bryant","year":"2016","unstructured":"Bryant AK, Fazeli PL, Letendre SL, Ellis RJ, Potter M, Burdo TH, et al. Complement component 3 is associated with metabolic comorbidities in older HIV-positive adults. AIDS Res Hum Retrovir. 2016;32:271\u20138.","journal-title":"AIDS Res Hum Retrovir"},{"key":"1240_CR86","first-page":"263","volume":"20","author":"M Kianpour","year":"2015","unstructured":"Kianpour M, Norozi S, Bahadoran P, Azadbakht L. The relationship between metabolic syndrome criteria and preeclampsia in primigravid women. Iran J Nurs Midwifery Res. 2015;20:263\u20138.","journal-title":"Iran J Nurs Midwifery Res"},{"key":"1240_CR87","first-page":"Cd003510","volume":"7","author":"N Siegfried","year":"2011","unstructured":"Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2011;7:Cd003510.","journal-title":"Cochrane Database Syst Rev"},{"key":"1240_CR88","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.preghy.2013.11.008","volume":"4","author":"D Hall","year":"2014","unstructured":"Hall D, Gebhardt S, Theron G, Grove D. Pre-eclampsia and gestational hypertension are less common in HIV infected women. Pregnancy Hypertens. 2014;4:91\u20136.","journal-title":"Pregnancy Hypertens"},{"issue":"5","key":"1240_CR89","doi-asserted-by":"publisher","first-page":"174","DOI":"10.5830\/CVJA-2013-029","volume":"24","author":"N Govender","year":"2013","unstructured":"Govender N, Naicker T, Moodley J. Maternal imbalance between pro-angiogenic and anti-angiogenic factors in HIV-infected women with pre-eclampsia. Cardiovasc J Afr. 2013;24(5):174\u20139.","journal-title":"Cardiovasc J Afr"},{"key":"1240_CR90","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/S0140-6736(02)11195-0","volume":"360","author":"RC Wimalasundera","year":"2002","unstructured":"Wimalasundera RC, Larbalestier N, Smith JH, de Ruiter A, Mc GTSA, Hughes AD, et al. Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet. 2002;360:1152\u20134.","journal-title":"Lancet"},{"key":"1240_CR91","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/01.aids.0000198090.70325.bd","volume":"20","author":"A Suy","year":"2006","unstructured":"Suy A, Martinez E, Coll O, Lonca M, Palacio M, de Lazzari E, et al. Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS. 2006;20:59\u201366.","journal-title":"AIDS"},{"key":"1240_CR92","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1097\/AOG.0000000000001424","volume":"127","author":"M Sansone","year":"2016","unstructured":"Sansone M, Sarno L, Saccone G, Berghella V, Maruotti GM, Migliucci A, et al. Risk of preeclampsia in human immunodeficiency virus-infected pregnant women. Obstet Gynecol. 2016;127:1027\u201332.","journal-title":"Obstet Gynecol"},{"key":"1240_CR93","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4236\/wjcd.2014.45034","volume":"4","author":"B Landi","year":"2014","unstructured":"Landi B, Bezzeccheri V, Guerra B, Piemontese M, Cervi F, Cecchi L, et al. HIV infection in pregnancy and the risk of gestational hypertension and preeclampsia. World J Cardiovasc Dis. 2014;4:11.","journal-title":"World J Cardiovasc Dis"},{"key":"1240_CR94","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5830\/CVJA-2012-078","volume":"24","author":"VMS Kalumba","year":"2013","unstructured":"Kalumba VMS, Moodley J, Naidoo TD. Is the prevalence of pre-eclampsia affected by HIV\/AIDS? A retrospective case\u2013control study. Cardiovasc J Afr. 2013;24:24\u20137.","journal-title":"Cardiovasc J Afr"},{"key":"1240_CR95","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S1701-2163(16)35156-8","volume":"34","author":"T Boyajian","year":"2012","unstructured":"Boyajian T, Shah PS, Murphy KE. Risk of preeclampsia in HIV-positive pregnant women receiving HAART: a matched cohort study. J Obstet Gynaecol Can. 2012;34:136\u201341.","journal-title":"J Obstet Gynaecol Can"},{"key":"1240_CR96","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijgo.2015.08.007","volume":"133","author":"JW Adams","year":"2016","unstructured":"Adams JW, Watts DH, Phelps BR. A systematic review of the effect of HIV infection and antiretroviral therapy on the risk of pre-eclampsia. Int J Gynaecol Obstet. 2016;133:17\u201321.","journal-title":"Int J Gynaecol Obstet"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-019-01240-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-019-01240-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-019-01240-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T10:15:05Z","timestamp":1721211305000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-019-01240-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,26]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1240"],"URL":"https:\/\/doi.org\/10.1007\/s00011-019-01240-0","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,26]]},"assertion":[{"value":"28 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}